Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

被引：0
|
作者：
Amanda Jane Leach
Christine Wigger
Kim Hare
Vanya Hampton
Jemima Beissbarth
Ross Andrews
Mark Chatfield
Heidi Smith-Vaughan
Peter Stanley Morris
机构：
[1] Charles Darwin University,Menzies School of Health Research
[2] Royal Darwin Hospital,undefined
来源：
BMC Pediatrics | / 15卷
关键词：
Nasopharynx; Nontypeable ; Otitis media; child; Indigenous; Pneumococcal vaccines; Prevalence; Surveillance; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine
    Leach, Amanda Jane
    Wigger, Christine
    Hare, Kim
    Hampton, Vanya
    Beissbarth, Jemima
    Andrews, Ross
    Chatfield, Mark
    Smith-Vaughan, Heidi
    Morris, Peter Stanley
    BMC PEDIATRICS, 2015, 15
  • [2] 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children
    Greg L. Plosker
    Pediatric Drugs, 2014, 16 : 425 - 444
  • [3] 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine: A Review in Infants and Children
    Plosker, Greg L.
    PEDIATRIC DRUGS, 2014, 16 (05) : 425 - 444
  • [4] Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)
    Silfverdal, Sven Arne
    Coremans, Vanessa
    Francois, Nancy
    Borys, Dorota
    Cleerbout, Jan
    EXPERT REVIEW OF VACCINES, 2017, 16 (02) : 109 - 121
  • [5] Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on pneumococcal disease
    Hausdorff, W.
    Mrkvan, T.
    Moreira, M.
    Guinazu, J. Ruiz
    Borys, D.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S157 - S157
  • [6] Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
    Chun-Yi Lu
    Ching-Hu Chung
    Li-Min Huang
    Eliza Kruger
    Seng-Chuen Tan
    Xu-Hao Zhang
    Nan-Chang Chiu
    Cost Effectiveness and Resource Allocation, 18
  • [7] Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage
    Prymula, Roman
    Hanovcova, Irena
    Splino, Miroslav
    Kriz, Pavia
    Motlova, Jitka
    Lebedova, Vera
    Lommel, Patricia
    Kaliskova, Eva
    Pascal, Thierry
    Borys, Dorota
    Schuerman, Lode
    VACCINE, 2011, 29 (10) : 1959 - 1967
  • [8] Correction to: Cost-effectiveness evaluation of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine for children in Taiwan
    Chun-Yi Lu
    Ching-Hu Chung
    Li-Min Huang
    Eliza Kruger
    Seng-Chuen Tan
    Xu-Hao Zhang
    Nan-Chang Chiu
    Cost Effectiveness and Resource Allocation, 19
  • [9] Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children
    Shiragami M.
    Mizukami A.
    Leeuwenkamp O.
    Mrkvan T.
    Delgleize E.
    Kurono Y.
    Iwata S.
    Infectious Diseases and Therapy, 2015, 4 (1) : 93 - 112
  • [10] MODELING THE OUTCOMES OF VACCINATION WITH THE 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SPAIN
    Mares, J.
    Moraga-Llop, F.
    Fenoll, A.
    Perez-Alcantara, F.
    Perez, I
    Morano, R.
    VALUE IN HEALTH, 2009, 12 (07) : A426 - A426
12345